Management of Chronic Mild WBC Elevation in Adults

Initial Assessment and Risk Stratification

The American College of Physicians recommends that a WBC count of ≥14,000 cells/mm³ or presence of a left shift warrants systematic evaluation for infection or hematologic malignancy, with a likelihood ratio of 3.7 for bacterial infection 1, 2
The presence of a left shift, even when total WBC is <14,000 cells/mm³, suggests active infection or bone marrow stress and warrants infection assessment 1, 2

The Infectious Diseases Society of America recommends that patients with WBC ≥14,000 cells/mm³ or left shift present, even without fever, should be suspected of having an infection and undergo systematic evaluation 1, 2
The American College of Emergency Physicians recommends that blood cultures should be obtained before antibiotics if systemic infection is suspected, and urinalysis and urine culture should be performed if infection is suspected 1, 2

The American College of Physicians recommends that if no infection or malignancy is identified, a repeat CBC with differential should be performed in 3 months to assess stability, and modifiable factors such as smoking cessation and optimization of chronic inflammatory conditions should be addressed 1
The Infectious Diseases Society of America recommends that if an infection is identified, it should be treated with appropriate antimicrobial therapy, and invasive procedures should be avoided until the infection is controlled 1

The National Comprehensive Cancer Network recommends that patients with chronic myelomonocytic leukemia (CMML) who experience a rapidly increasing WBC count without signs of infection should undergo restaging with bone marrow workup and molecular studies 3
The European Society for Medical Oncology recommends that myeloproliferative CMML with low blast count should be treated with hydroxyurea as first-line cytoreductive therapy 4, 5
The American Society of Pediatric Hematology/Oncology recommends that pediatric patients with hyperleukocytosis (WBC >100 × 10⁹/L) should receive immediate intervention with IV hydration and hydroxyurea before initiating tyrosine kinase inhibitors 6